261 results on '"Fan, Xing-Xing"'
Search Results
2. Longitudinal high-dimensional analysis identifies immune features associating with response to anti-PD-1 immunotherapy
3. Circular RNAs: Potential biomarkers and therapeutic targets for autoimmune diseases
4. Pharmacokinetics, absorption and transport mechanism for ginseng polysaccharides
5. β-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer
6. DMU-212 against EGFR-mutant non-small cell lung cancer via AMPK/PI3K/Erk signaling pathway
7. Tumor PKCδ instigates immune exclusion in EGFR-mutated non–small cell lung cancer
8. PA-MSHA induces inflamed tumor microenvironment and sensitizes tumor to anti-PD-1 therapy
9. Novel clinical biomarkers in blood and pleural effusion for diagnosing patients with tuberculosis distinguishing from malignant tumor
10. Low-dimensional nanomaterials enabled autoimmune disease treatments: Recent advances, strategies, and future challenges
11. The Scientific Foundation of Chinese Herbal Medicine against COVID-19
12. ZYZ384 suppresses the growth of EGFR‐mutant non‐small cell lung cancer by activating JNK/MAPK signaling pathway
13. Prognostic significance of tumor poliovirus receptor and CTLA4 expression in patients with surgically resected non-small-cell lung cancer
14. Targeting Two Antigens Associated with B-ALL with CD19-CD123 Compound Car T Cell Therapy
15. Characterization of an Anti-CD5 Directed CAR T-Cell against T-Cell Malignancies
16. ZYZ384 suppresses the growth of EGFR‐mutant non‐small cell lung cancer by activating JNK/MAPK signaling pathway.
17. Current strategies against COVID-19
18. Evodiamine suppresses non-small cell lung cancer by elevating CD8+ T cells and downregulating the MUC1-C/PD-L1 axis
19. ROS-Responsive Berberine Polymeric Micelles Effectively Suppressed the Inflammation of Rheumatoid Arthritis by Targeting Mitochondria
20. Antiangiogenesis-Combined Photothermal Therapy in the Second Near-Infrared Window at Laser Powers Below the Skin Tolerance Threshold
21. MicroRNA-421 confers paclitaxel resistance by binding to the KEAP1 3′UTR and predicts poor survival in non-small cell lung cancer
22. Overcoming Suppressive Tumor Microenvironment by Vaccines in Solid Tumor
23. Circular Rnas: Potential Biomarkers and Therapeutic Targets for Autoimmune Diseases
24. Holistic immunomodulation for small cell lung cancer
25. Quantitative evaluation of berberine subcellular distribution and cellular accumulation in non-small cell lung cancer cells by UPLC–MS/MS
26. p53 sensitizes chemoresistant non-small cell lung cancer via elevation of reactive oxygen species and suppression of EGFR/PI3K/AKT signaling
27. Detection of Single Cancer Cell Multidrug Resistance With Single Cell Bioanalyzer.
28. Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer
29. Nanotechnology-based chimeric antigen receptor T-cell therapy in treating solid tumor
30. Unraveling the dynamic interplay between mechanical stress and bone homeostasis.
31. Chelerythrine ameliorates rheumatoid arthritis by modulating the AMPK/mTOR/ULK-1 signaling pathway
32. Bacteria-based nanodrug for anticancer therapy
33. Proscillaridin A induces apoptosis and suppresses non-small-cell lung cancer tumor growth via calcium-induced DR4 upregulation
34. Inhibition of KRAS-dependent lung cancer cell growth by deltarasin: blockage of autophagy increases its cytotoxicity
35. Network structure entropy and its dynamical evolution for recurrence networks from earthquake magnitude time series
36. Decoding Lung Cancer at Single-Cell Level
37. Andrographolide suppresses non-small-cell lung cancer progression through induction of autophagy and antitumor immune response
38. Xihuang pills induce apoptosis in hepatocellular carcinoma by suppressing phosphoinositide 3-kinase/protein kinase-B/mechanistic target of rapamycin pathway
39. Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway
40. A method establishment and comparison of in vivo lung cancer model development platforms for evaluation of tumour metabolism and pharmaceutical efficacy
41. DMU-212 Against EGFR-Mutant Non-Small Cell Lung Cancer Via AMPK/PI3K/Erk Signaling Pathway
42. Emodin induces apoptosis and suppresses non-small-cell lung cancer growth via downregulation of sPLA2-IIa
43. Resistance looms for KRAS G12C inhibitors and rational tackling strategies
44. PA-MSHA Induces Inflamed Tumor Microenvironment and Sensitizes Tumor to Anti-PD-1 Therapy
45. Novel clinical biomarkers in blood and pleural effusion for diagnosing patients with tuberculosis distinguishing from malignant tumor
46. Quantification of Osimertinib and Metabolite–Protein Modification Reveals Its High Potency and Long Duration of Effects on Target Organs
47. Longitudinal high-dimensional analysis identifies biomarkers of response to anti-PD-1 immunotherapy
48. Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer
49. Pyronaridine induces apoptosis in non‐small cell lung cancer cells by upregulating death receptor 5 expression and inhibiting epidermal growth factor receptor
50. Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8+ T cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.